Connect with us

Health

India’s Bharat Biotech gets official approval to test nasal COVID-19 shot as booster

India vaccine manufacturer Bharat Biotech on Wednesday got ‘in principle’ approval from the country’s drug regulator to test nasal COVID-19 vaccine as a booster shot.
The drug regulator DCGI granted approval to Hyderabad-based Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.

Read the latest updates in our dedicated coronavirus section.

Meanwhile, India on Wednesday reported 58,097 new COVID-19 cases, 124 deaths in last 24 hours. The government said that the country has reported 2,135 omicron cases so far.

For the latest headlines, follow our Google News channel online or via the app.

Read more: India launches drive to vaccinate children before a feared omicron surge

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Pandemic experts express concern over avian influenza spread to humans

The ongoing global spread of “bird flu” infections to mammals including humans is a significant public health concern, senior UN medics said on Thursday, as they announced new measures to tackle airborne diseases.

Continue Reading

Health

Violations of women’s reproductive health rights trigger rise in preventable deaths

African women are 130 times more likely to die due to pregnancy or childbirth complications than women in Europe and Northern America, the UN sexual and reproductive health agency (UNFPA) said in a new report published on Wednesday.

Continue Reading

Health

Nigeria first country to introduce ‘revolutionary’ meningitis vaccine

Nigeria has become the first country to roll out a “revolutionary” five-in-one vaccine against meningitis, the World Health Organization (WHO) said in a statement on Friday.

Continue Reading

Trending